Color Genomics, the genetic testing company, is partnering with Alphabet's healthcare technology subsidiary, Verily Life Sciences, to provide information from its genetic testing to participants in the company's baseline health study.
The focus of both companies is on providing information "actionable" results.
While genetic testing has led the public to gain insight into an individual's ancestry, technology has proven less effective in providing health insights that are accurate enough to be clinically relevant.  The partnership will provide Project Baseline Health participants with access to Color's Genomics Diagnostic Testing Services, as well as to corporate-certified genetic counselors and pharmacists, to understand which genetic tests assess their risks to certain cancers, Heart disease, indications and genes that can affect medication responses, the company said.
Verily tries to trick people into trying to create a map of the general health status of the population using the latest data science and testing technologies.
Color's genetic testing can be ordered online, with participants taking their own samples at home. The users then receive telephone counseling and the tests are performed. Within weeks, the company said.
By providing color counseling services, Verily aims to ensure that the genetic information received by participants in the "baseline" study benefits both individuals and the architect of the study. [1